In this episode, Kabir Patel and Shashank Garg explore the emergence of Agentic AI—intelligent systems capable of autonomous decision-making—and its transformative impact on the pharmaceutical industry. Kabir highlights how AI is evolving beyond automation, enabling autonomous decision-making and breakthrough innovations in drug discovery and materials science. They also explore how AI is shifting from standardization to hyper-personalization, making tailored experiences more accessible. With enterprises at a turning point, the discussion delves into how AI is redefining work, reshaping industries, and unlocking new possibilities.